Molecular Designs appears in FDA 510(k) records as the applicant for K262789, received August 6, 2026 and decided November 4, 2026 with decision code SESE, meaning substantially equivalent. The device named in the filing is the SimplicityDx Panel FluA/FluB/RSV, classified under product code OCC with regulation number 866.3980 and device class 2, within the microbiology advisory committee. The filing lists a Traditional clearance type, no third-party review, and a summary as the statement or summary type. The company’s own published pages describe a broader Simplicity product family, including panels, collection devices and extraction reagents, and state that certain components carry different regulatory status than the cleared panel. [1][3][4]
The cleared respiratory panel and its filing scope
K262789 covers the SimplicityDx Panel FluA/FluB/RSV, a respiratory virus panel nucleic acid assay system. The FDA record lists the applicant as Molecular Designs at 2 Perimeter Park Suite 200W, Birmingham, AL 35243, and the openFDA device name as Respiratory Virus Panel Nucleic Acid Assay System. The decision description is Substantially Equivalent, with a Traditional clearance type and no expedited review flag. The review advisory committee is microbiology, matching the advisory committee field. [1]
The published decision summary for K262789 references CLSI guidance documents, including EP37 for interference testing, MM17 for verification and validation of multiplex nucleic acid assays, and EP05-A3 for precision evaluation. Those references describe the standards cited in the review document; they do not establish performance results for the panel. [8]
Published product family beyond the cleared panel
Molecular Designs’ published site describes Simplicity Panels, with links to a product overview, panels, assays and a Simplicity Panels whitepaper, and invites laboratories to request a physical demo box. The same pages describe an Opti-Swab Liquid Amies Transport System for collection and transport of viral and bacterial pathogens, and nylon flocked nasopharyngeal and oropharyngeal swabs. [3][4]
The manufacturer’s published footer states that 510(k) clearance applies to K262789, that Simplicity Collection and Simplicity Extraction are FDA Class I devices registered and listed, and that Simplicity Panels are for research use only and not for use in diagnostic procedures. A separate portfolio page repeats the research-use-only statement for all products. These are the manufacturer’s own regulatory characterizations, not FDA determinations reproduced here. [4][6]
Corporate identity and published credentials
The company’s published contact block lists 2 Perimeter Park South, Suite 200W, Birmingham, AL 35243, with a toll-free number and a customer success email address, and displays an ISO 13485:2016 certification mark attributed to Intertek. The same footer carries a copyright notice for 2026. No parent company, brand owner or corporate affiliate is identified in the numbered sources, so the relationship between Molecular Designs and any other entity is unknown. [4][7]
A company blog post is titled as announcing the first FDA clearance for the SimplicityDx Panel FluA/FluB/RSV. The numbered excerpt of that page does not include the article body, so the post’s substantive statements are not characterized here. [5]
What the record collection shows
The linked FDA record collection contains one 510(k) entry, K262789, with one SESE decision, and no recall records. The explicitly smaller record sample likewise contains that single entry and one SESE decision. These counts describe the linked filings as of the snapshot date and are not measures of total company sales, total portfolio size or safety performance. [1]

